15 results
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
diseases - Severe ... pericarditis SCAP severe ... #Pharmacology # ... Management #Treatment ... #Indications
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
Non-Intensivist Infection ... Risk Factors for Severe ... COVID-19 Specific Medications ... #COVID19 #ICU #criticalcare ... NonIntensivist #diagnosis #management
IDSA Algorithm for the Management of Purulent skin and soft tissue infections (SSTIs). 
Mild infection: for
IDSA Algorithm for ... the Management ... Severe infection ... Severe infection ... #cellulitis #idsa
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
Over-anticoagulation can lead to severe ... #management #algorithm ... #pharmacology # ... treatment #medications ... #decisionaid #cardiology
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
correlate with severe ... Common adverse effects ... respiratory tract infection ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
Checklist for Treatment of Delirium in the ICU 

Remove causative factors 
 - 
Exclude hypoglycemia if
- Review the medication ... or persistent fevers ... patients with severe ... Delirium #Checklist #Management ... Treatment #MICU #CriticalCare
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... daily Treating Severe ... Coccidiodomycosis #IDSA ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
IDSA - Diabetic Foot Infections - Suggested Route, Setting, and Duration of Antibiotic Therapy, by Clinical
IDSA - Diabetic ... Foot Infections ... Moderate 1–3 wk • Severe ... #antibiotics #pharmacology ... #management
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... TID Treating Severe ... HerpesSimplex #HSV #IDSA ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
Dupixent (dupilumab) for Asthma
Dupixent (dupilumab) is a biologic medication that is a dual inhibitor of IL4
is a biologic medication ... in moderate-to-severe ... every 2 weeks. ... dupilumab #Asthma #Management ... #Pharmacology